<DOC>
	<DOC>NCT00254475</DOC>
	<brief_summary>The purpose of this study is to provide data on the dose response of simvastatin in lowering LDL-C when it is co-administered with valsartan in patients with both essential hypertension and hypercholesterolemia. The primary objective of the study will be to show that the combination of valsartan 160mg/simvastatin 40mg has superior efficacy compared to the combination of valsartan 160mg/simvastatin 20mg in percentage change from baseline in LDL-C.</brief_summary>
	<brief_title>A Study to Evaluate the Efficacy of Valsartan/Simvastatin Combinations in Patients With Both Essential Hypertension and Hypercholesterolemia</brief_title>
	<detailed_description />
	<mesh_term>Hypertension</mesh_term>
	<mesh_term>Hypercholesterolemia</mesh_term>
	<mesh_term>Valsartan</mesh_term>
	<mesh_term>Simvastatin</mesh_term>
	<criteria>Elevated LDLCholesterol Essential hypertension Severe Hypertension Prior or known muscular or neuromuscular disease of any type A history of cardiovascular disease Hypertension or hypercholesterolemia due to secondary causes Uncontrolled diabetes or insulin treatment Evidence of hepatic or renal disease Other protocoldefined exclusion criteria may apply</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2014</verification_date>
	<keyword>Valsartan</keyword>
	<keyword>simvastatin</keyword>
	<keyword>hypertension</keyword>
	<keyword>hypercholesterolemia</keyword>
	<keyword>angiotensin II receptor blocker</keyword>
</DOC>